Roche buys majority stake in US genomics analysis business Swiss pharmaceutical giant Roche on Tuesday announced it had acquired a majority stake in US molecular and genomic analysis business Foundation Medicine for an undisclosed sum. 9 years ago by Guardian Nigeria